Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520832 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys
A Phase 2 study of Primary Insomnia, sponsored by Logan College of Chiropractic.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00520832: Completed Phase 2 study of Primary Insomnia, sponsored by Logan College of Chiropractic.
NCT00520832 is a Phase 2 study of Primary Insomnia that has completed, run by Logan College of Chiropractic. The registered enrollment target is 20 participants, below the 124-participant average among 12 other Primary Insomnia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00520832, a Phase 2 study of Primary Insomnia, has completed, sponsored by Logan College of Chiropractic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia. The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.
Conditions Studied
Interventions
- DEVICE Microcurrent
Study Locations (1)
Missouri
- Logan College of Chiropractic - Chesterfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00520832 record still lists
NCT00520832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 124-participant average among 12 other Primary Insomnia trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Primary Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Microcurrent is the first listed.
NCT00520832 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00520832 about?
NCT00520832 is a clinical study titled "A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys". Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia. The hypothesis is that the experimental group ...
What is the current status of trial NCT00520832?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2007-09. Estimated completion is 2007-12.
What conditions does trial NCT00520832 study?
This clinical trial studies the following conditions: Primary Insomnia.
What interventions are being tested in trial NCT00520832?
The interventions under investigation include: Microcurrent (DEVICE).
Who is sponsoring clinical trial NCT00520832?
This trial is sponsored by Logan College of Chiropractic, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00520832 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00520832's enrollment target sits among peer trials
20 12th of 12 higher than 1 of 12 other Primary Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Primary Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Two Contrasting Interventions for Sleep Management
COMPLETED · Phase 2
-
Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study
COMPLETED · Phase 2
-
The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia
COMPLETED · Phase 4
-
Comparison of Two Temperatures to Treat Insomnia
COMPLETED · NA
-
The Psychoneuroimmunology of Insomnia
COMPLETED
-
Sleep Homeostasis in Primary Insomnia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia